ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.52
-1.13%
US Tech 100
20,263.20
-1.69%
S&P 500
5,827.04
-1.54%
US Dollar vs CAD
1.4426
0.00%
Bitcoin
95,087.20
0.55%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. uniQure NV (QURE)

  7. uniQure NV (QURE) News

QURE

uniQure NV (QURE)

uniQure NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QURE
DateTimeSourceHeadlineSymbolCompany
01/08/20253:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
01/08/20253:21PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:QUREuniQure NV
01/08/20256:05AMGlobeNewswire Inc.uniQure Announces Pricing of its Public OfferingNASDAQ:QUREuniQure NV
01/07/20254:25PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:QUREuniQure NV
01/07/20253:49PMGlobeNewswire Inc.uniQure Announces Proposed Public OfferingNASDAQ:QUREuniQure NV
01/07/20253:42PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:QUREuniQure NV
12/10/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QUREuniQure NV
12/10/20243:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QUREuniQure NV
12/10/20246:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
12/10/20246:05AMGlobeNewswire Inc.uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s DiseaseNASDAQ:QUREuniQure NV
11/21/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
11/21/20246:05AMGlobeNewswire Inc.uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe EpilepsyNASDAQ:QUREuniQure NV
11/14/202411:01AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
11/05/20248:08AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QUREuniQure NV
11/05/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
11/05/20246:05AMGlobeNewswire Inc.uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
10/25/20248:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
10/25/20248:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
10/15/20246:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
10/15/20246:05AMGlobeNewswire Inc.uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALSNASDAQ:QUREuniQure NV
09/23/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
09/23/20246:05AMGlobeNewswire Inc.uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry DiseaseNASDAQ:QUREuniQure NV
08/15/20246:48AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
08/15/20246:05AMGlobeNewswire Inc.uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry DiseaseNASDAQ:QUREuniQure NV
08/01/20247:54AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QUREuniQure NV
08/01/20246:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
08/01/20246:43AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QUREuniQure NV
08/01/20246:05AMGlobeNewswire Inc.uniQure Announces Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:QUREuniQure NV
07/23/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
07/23/20246:05AMGlobeNewswire Inc.uniQure Announces Closing of Sale of Manufacturing Facility to GenezenNASDAQ:QUREuniQure NV
 Showing the most relevant articles for your search:NASDAQ:QURE

Your Recent History

LSE
QI88
Morg.st.b.v 24
LSE
RS11
Morg.st.b.v 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads